IMLYGIC, an Unresectable Melanoma Treatment, Gets Positive CHMP Opinion
News
Amgen announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), has given a positive recommendation for IMLYGIC (talimogene laherparepvec) as a treatment for adult ... Read more